CD33 CAR-T cell
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD33 CAR-T cell, covering 2025-01-07 to 2025-01-07. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study to Explore the Safety and Efficacy of CD33 CAR-T Cell in Relapsed/Refractory Acute Myeloid Leukemia [EARLY_Phase 1]